Fresenius Medical Care AG & Co. KGaA (FME) Given a €88.00 Price Target by Commerzbank Ag Analysts

Fresenius Medical Care AG & Co. KGaA (ETR:FME) received a €88.00 ($103.53) target price from stock analysts at Commerzbank Ag in a research note issued on Tuesday, August 1st. The brokerage currently has a “neutral” rating on the stock.

FME has been the subject of a number of other reports. Morgan Stanley set a €90.00 ($105.88) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a “buy” rating in a research note on Friday, May 5th. Deutsche Bank AG set a €87.00 ($102.35) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “neutral” rating in a research note on Monday, May 8th. J P Morgan Chase & Co set a €104.50 ($122.94) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a research note on Thursday, May 4th. Oddo Securities set a €95.00 ($111.76) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a research note on Monday, June 12th. Finally, Kepler Capital Markets set a €95.00 ($111.76) price objective on shares of Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a research note on Wednesday, May 3rd. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and ten have given a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average price target of €88.21 ($103.78).

Shares of Fresenius Medical Care AG & Co. KGaA (FME) opened at 79.18 on Tuesday. The firm has a market cap of €24.30 billion and a P/E ratio of 20.42. The company has a 50 day moving average price of €81.50 and a 200-day moving average price of €81.20. Fresenius Medical Care AG & Co. KGaA has a 52-week low of €70.82 and a 52-week high of €89.07.

ILLEGAL ACTIVITY WARNING: “Fresenius Medical Care AG & Co. KGaA (FME) Given a €88.00 Price Target by Commerzbank Ag Analysts” was first posted by Community Financial News and is the property of of Community Financial News. If you are viewing this piece of content on another domain, it was illegally copied and republished in violation of US & international copyright laws. The original version of this piece of content can be viewed at https://www.com-unik.info/2017/08/19/fresenius-medical-care-ag-88-00-price-target-by-commerzbank-ag-analysts-updated-updated.html.

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure.

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

What are top analysts saying about Fresenius Medical Care AG & Co. KGaA? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Fresenius Medical Care AG & Co. KGaA and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit